ClinicalTrials.gg
RecruitingNCT07654270Updated Nov 6, 2026

The Effect of Water Temperature on Heart Rate Variability and Cognition

An interventional study of water in Mental Acuity, sponsored by Arizona State University. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Arizona State University · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Updated Nov 6, 2026Now RecruitingFirst site in United States+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Female
01

Study summary

Heart rate variability (HRV) is a key indicator of fitness, and stress resilience. Previous research has shown that HRV decreases under mental workload, including during tasks that require strict attention. Studies also show that temperature exposure affects attention: cold increases the stress response while warm water has a calming effect. Very few studies combine thermal exposure with cognitive testing, and no controlled trials have investigated whether water temperature modulates HRV responses specifically during cognitive demand.

Read the detailed description

Heart rate variability (HRV) is a widely recognized physiological marker that reflects the dynamic interaction between the cardiovascular and autonomic nervous systems. HRV represents millisecond-level fluctuations in time between consecutive heartbeats. It is a key indicator of autonomic nervous system balance, with higher values indicate better recovery, fitness, and stress resilience. Previous research has shown that HRV decreases under mental workload, including during tasks that require attention, inhibition, or executive function.1-3 Studies also show that temperature exposure affects autonomic regulation: cold increases sympathetic drive, while warm water supports parasympathetic activation.4-6 Very few studies combine thermal exposure with cognitive testing, and no controlled trials have investigated whether water temperature modulates HRV responses specifically during cognitive demand.

02

Conditions studied

  • Mental Acuity

Keywords

  • heart rate variability
  • water temperature
  • cognitive performance
03

In context

Lead sponsor

Arizona State University is the lead sponsor of 239 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy women free of chronic disease (by self-report)
  • 18-30 years of age

Exclusion criteria

Exclusion Criteria:

  • medication/drug use that has not been consistent for the previous 3 months or will be discontinued during the trial
  • any acute illness
  • regular use of cigarettes or marijuana
  • pregnant or lactating women
  • not fluent in English
  • not willing to attend two in-person lab visits in downtown Phoenix and follow study protocol (including abstaining from caffeine in the 12 hours prior to testing)
  • not currently competing in sports or unusually high-intensity exercise protocols (e.g., high-intensity exercise greater than 30 minutes most days of the week)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Warm water

    Water will be heated to \~55º C (131 ºF)

    Other: water

  • Placebo comparator
    Cold water

    Cold water: 4-6º C (41ºF)

    Other: water

Interventions

  • Otherwater

    water temperature

06

What researchers measure

Primary outcomes

  1. heart rate variability

    the measure of the variation in time between consecutive heartbeats

    Time frame: 3 minutes

  2. cognitive performance

    Trail making test that measures cognitive flexibility, visual attention, and executive function, with interpretation based on completion times (in seconds)

    Time frame: 3 minutes

Secondary outcomes

  1. cognitive performance

    Stroop Color-Word Test which measures attention span, reaction time, and ability to resist distractions

    Time frame: 3 minutes

  2. cognitive performance

    reaction time: measured by the elapsed time between stimulus onset and an individual's response

    Time frame: 3 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2026 (actual). Primary completion is estimated for Dec 2026, 5 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2026
First posted
Jun 17, 2026
StartActual
Jul 13, 2026
Primary completionEst.
Dec 15, 2026
CompletionEst.
Jun 15, 2027
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 6, 2026
Sites
1 site added — first site in United States
Show site
  • Health North ASU Downtown Campus · Phoenix, United States
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in United States
    Show site
    • Health North ASU Downtown Campus · Phoenix, United States
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07654270
Responsible party
Carol Johnston (Professor and Senior Associate Dean, Arizona State University) — Principal investigator
First posted
Jun 17, 2026
Start date
Jul 13, 2026
Primary completion
Dec 15, 2026 (estimated)
Completion
Jun 15, 2027 (estimated)
Last update
Nov 6, 2026

Study contacts

Carol Johnston
Contact
carol.johnston@asu.edu
6024963463
Carol Johnston
principal investigator · Arizona State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion